Discount available for bulk order (contact Simone da Silva Rosa for more information)

RUO and not available for clinical diagnostic purposes. Regulatory approvals are pending in several regions.

This kit can be used for the qualitative measurement of SARS-CoV-2 neutralizing antibodies in human serum, plasma and whole blood.

The SARS-CoV-2 virus is a new type of coronavirus of the genus β, encoding four major structural proteins: spike (S), envelope (E), membrane (M) and nucleocapsid (N). The neutralizing antibodies can target the S1 subunit of S protein and bind to the S1 receptor binding domain (RBD), thereby blocking the interaction between S1RBD of the virus and angiotensin-converting enzyme 2 (ACE2) on the surface of human cells, alleviate the threat from SARS-CoV-2. The detection of neutralizing antibodies can be used to monitor the immune response of vaccinated people or people infected by SARS-CoV-2.

This product is for research use only.

Catalog Number: 41A260

Size: 25 tests per kit

Product Data Sheet: https://www.torontobioscience.com/41a260/

Price in USD